Measuring treatment compliance for sleep apnea in heart disease patients
Official title: Patients with Coronary Artery Disease or At High Cardiovascular Risk: Measuring Compliance with Treatment for Obstructive Sleep Apnea Syndrome (OAM or CPAP)
Run by University Hospital, Montpellier · NCT06568159 · Data updated 2026-11-12
This study tests how well heart disease patients with sleep apnea stick to using two different treatments, a CPAP machine and a mouthpiece, to see which one they find easier to use.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 1 site (Montpellier) |
| Status | Recruiting |
| Started | February 14, 2025 |
| Main results expected | February 14, 2026 |
| Study ends | February 15, 2026 |
| Registry record updated | February 18, 2025 |
| Trial ID | NCT06568159 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with coronary artery disease or at high cardiovascular risk who have moderate to severe obstructive sleep apnea.
✕Probably not a fit
Patients with unstable heart failure or severe psychiatric disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the compliance, tolerance, and usability of two treatments for obstructive sleep apnea (OSA) in patients with coronary artery disease or those at high cardiovascular risk. The study compares the standard continuous positive airway pressure (CPAP) therapy with a mandibular advancement device (MAD), which may be better tolerated by patients. Participants will include those with moderate to severe OSA, and the study will evaluate how well they adhere to these treatments. The findings could provide insights into the effectiveness of these therapies in a high-risk population.
Why it matters
Potential benefit: If successful, this study could improve treatment adherence and outcomes for patients with obstructive sleep apnea and coronary artery disease.
How similar studies have gone: Previous studies have shown that alternative treatments like MAD can be effective for patients who struggle with CPAP, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Target population: with coronary artery disease or at very high risk of coronary artery disease: * Patients with coronary artery disease with or without co-morbidities (smoking, diabetes, hypertension, dyslipidaemia, renal insufficiency, overweight, emerging factors including anxiety-depression, shift workers, etc.). * Hypertensive patients at high cardiovascular risk (target organ damage such as LVH or albuminuria) * Diabetic patients at high cardiovascular risk * Type of heart disease: ischaemic heart disease without clinically significant heart failure (NYHA II, III, IV) For the experimental group (MAD): patients with moderate or severe OSA with intolerance or refusal of CPAP and managed by MAD. For the control group (CPAP): patients with moderate or severe OSA treated with CPAP. Exclusion Criteria: * Patients with heart failure not stabilised according to the investigator (NYHA IV) * Severe psychiatric disorders * Pregnant or breast-feeding women * Opposition to participation after a period of reflection * Not affiliated to a social security scheme, * Persons under court protection, * Persons under guardianship or curatorship * Person taking part in another study with an exclusion period still in progress * Inability to follow the patient during the study period.
Where it's running
-
CHU de MONTPELLIER
Montpellier, France Recruiting
Study contacts
- Study coordinator: Cindy FRANCOIS
- Email: c-francois@chu-montpellier.fr
- Phone: 06 84 31 62 08
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions
This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.
-
Comparing heart imaging techniques for coronary artery disease
This study is testing if a new heart imaging method can better identify problems in patients suspected of having coronary artery disease compared to a traditional imaging technique.
-
Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients
This study tests whether taking one antiplatelet medicine is as safe and causes less bleeding than taking two medicines for people aged 75 or older, or adults at high bleeding risk, after drug-coated balloon angioplasty for coronary artery disease.
-
Evaluating the effectiveness and safety of Synergy XD and Megatron stents
This study is testing how well and safely the Synergy XD and Megatron stents work for people with coronary artery disease compared to other stents in real-life situations.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.